Alterity Therapeutics Ltd (NASDAQ:ATHE)
| 2.75 Delayed Data As of 3:04pm ET |  -0.005 / -0.18%Today’s Change | 2.53 Today|||52-Week Range 8.73 | -21.17% Year-to-Date |
Latest ATHE News | Press Releases
No recent news for Alterity Therapeutics Ltd.
Today’s Trading
| Previous close | 2.75 |
| Today’s open | 2.90 |
| Day’s range | 2.75 - 2.90 |
| Volume | 8 |
| Average volume (3 months) | 23,689 |
| Market cap | $10.9M |
Data as of 3:04pm ET, 03/29/2023
Growth & Valuation
| Earnings growth (last year) | +42.45% |
| Earnings growth (this year) | -67.78% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.44 |
Competitors
| ---- | ||
| PULMPulmatrix Inc | 0.00 | 0.00% |
| RDHLRedhill Biopharma Lt... | -0.09 | -1.86% |
| JAGXJaguar Health Inc | -0.05 | -6.38% |
Data as of 3:59pm ET, 03/29/2023
Financials
| Last reporting date | August 31, 2022 |
| EPS forecast (this quarter) | -$1.97 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$9.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Melbourne, Victoria (vic) |
Forecasts
